Chinese Journal of Pharmacovigilance ›› 2021, Vol. 18 ›› Issue (7): 686-688.
DOI: 10.19803/j.1672-8629.2021.07.19

Previous Articles     Next Articles

Bibliometric Analysis of Pharmacovigilance Research in China

ZHENG Mingjie1, ChENG Rong2, SONG Haibo1,*   

  1. 1Center for Drug Reevaluation, NMPA, Beijing 100022, China;
    2Center for Drug Reevaluation, Guiyang Guizhou 550081, China
  • Received:2020-04-14 Online:2021-07-15 Published:2021-07-23

Abstract: Objective To analyze the current status and shortcomings of pharmacovigilance research in China and provide references for promoting pharmacovigilance research. Methods Literatures related to pharmacovigilance and Pharmacovigilance of PubMed and CNKI from the establishment of the database to 31 December 2020 were searched and analyzed. The trends of pharmacovigilance research at home and abroad were compared. The current status and deficiencies of relevant research in China were analyzed. Results The research on pharmacovigilance in China still focuses on traditional adverse drug reaction monitoring, mainly involving pharmacy, traditional Chinese medicine and preventive medicine., which may be due to the fact that China's pharmacovigilance system has just been implemented, domestic colleges and universities lack academic education in the field of pharmacovigilance, medical institutions and enterprises are not highly involved in pharmacovigilance research, and scientific research management departments have insufficient funding for pharmacovigilance research. Most academic journals do not regard pharmacovigilance related research as a key area of publication. Conclusion Effective measures should be taken to promote the research development and system implementation of pharmacovigilance in China.

Key words: pharmacovigilance, bibliometrics, adverse drug reactions, risk management

CLC Number: